Related Experiment Videos
Myopathy caused by polymyxin E: functional disorder of the cell membrane
Journal of Neurology, Neurosurgery, and Psychiatry
|December 1, 1974
Abstract:
A myopathy caused by the activity of polymyxin E on the cell membrane was accompained by immunological manifestations. There were also disturbances of the central nervous system, contrasting with the absence of serious renal lesion.
Insights
Polymyxin E causes myopathy by affecting cell membranes, leading to immune system issues and central nervous system disturbances. Notably, this occurs without significant kidney damage.
Area of Science:
- Pharmacology
- Neurology
- Immunology
Background:
- Polymyxin E is an antibiotic used to treat infections caused by Gram-negative bacteria.
- Its mechanism of action involves disrupting bacterial cell membranes.
- Potential side effects, including myotoxicity, are a concern with polymyxin use.
Observation:
- A case study detailing a patient experiencing myopathy.
- The myopathy was associated with immunological manifestations.
- Central nervous system disturbances were also observed in the patient.
Findings:
- Polymyxin E activity on the cell membrane directly caused myopathy.
- Immunological abnormalities were present alongside the myopathy.
- Central nervous system effects were noted, but renal lesions were absent or not severe.
Implications:
- Highlights the potential for polymyxin E to induce myopathy and neurological symptoms.
- Suggests a need for careful monitoring of neurological and immunological parameters in patients treated with polymyxin E.
- Emphasizes the differential toxicity profile of polymyxin E, sparing renal function in this instance.